The Most Important Piece of Advice for Raising Medtech Venture Capital

identifeye HEALTH is developing an AI-enabled retinal imaging platform that doesn't require complex equipment or specialized operators. Using advanced algorithms and automated systems, the technology captures and analyzes retinal images to detect early signs of disease while improving accessibility to preventive healthcare. In this interview, CEO Vicky Demas challenges founders to consider: Are you building a diagnostic solution that can scale globally or a product limited to specialized healthcare settings? She also discusses why understanding real-world implementation challenges early can prevent costly missteps later.

Axena Health is transforming pelvic floor therapy with Leva, a device bringing clinically-proven, supervised pelvic floor muscle training into women’s homes. In this interview, Randy Pritchard and Erica Rogers share essential medtech commercialization insights: identify your specific patient segment, build continuous clinical evidence, and communicate consistently with investors. Their experience offers invaluable lessons for medical device entrepreneurs navigating today's complex healthcare landscape.

EDAP is changing prostate cancer treatment through Focal One, a robotic high-intensity focused ultrasound (HIFU) system that doesn’t require use of surgery or radiation. In this interview, Ryan Rhodes challenges founders to ask: Are you creating a scalable medtech solution or a product with limited growth potential? He unpacks why standardization and scalability are critical for adoption, how clinical data fuels credibility and reimbursement, and why early adopters take the biggest risks — but also reap the biggest rewards.